Viewing Study NCT03015857


Ignite Creation Date: 2025-12-24 @ 6:39 PM
Ignite Modification Date: 2025-12-30 @ 8:03 PM
Study NCT ID: NCT03015857
Status: COMPLETED
Last Update Posted: 2017-05-03
First Post: 2016-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D010656', 'term': 'Phenylephrine'}, {'id': 'D009638', 'term': 'Norepinephrine'}, {'id': 'D002045', 'term': 'Bupivacaine'}, {'id': 'D005283', 'term': 'Fentanyl'}, {'id': 'D000077330', 'term': 'Saline Solution'}], 'ancestors': [{'id': 'D004983', 'term': 'Ethanolamines'}, {'id': 'D000605', 'term': 'Amino Alcohols'}, {'id': 'D000438', 'term': 'Alcohols'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D000588', 'term': 'Amines'}, {'id': 'D015306', 'term': 'Biogenic Monoamines'}, {'id': 'D001679', 'term': 'Biogenic Amines'}, {'id': 'D002395', 'term': 'Catecholamines'}, {'id': 'D002396', 'term': 'Catechols'}, {'id': 'D010636', 'term': 'Phenols'}, {'id': 'D001555', 'term': 'Benzene Derivatives'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D000813', 'term': 'Anilides'}, {'id': 'D000577', 'term': 'Amides'}, {'id': 'D000814', 'term': 'Aniline Compounds'}, {'id': 'D010880', 'term': 'Piperidines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D000077324', 'term': 'Crystalloid Solutions'}, {'id': 'D007552', 'term': 'Isotonic Solutions'}, {'id': 'D012996', 'term': 'Solutions'}, {'id': 'D004364', 'term': 'Pharmaceutical Preparations'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 200}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2017-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-05', 'completionDateStruct': {'date': '2017-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-05-01', 'studyFirstSubmitDate': '2016-12-05', 'studyFirstSubmitQcDate': '2017-01-07', 'lastUpdatePostDateStruct': {'date': '2017-05-03', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2017-01-10', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2017-03', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Incidence of post spinal hypotension (PSH) defined as percentage of patients with decreased systolic blood pressure less than 80% of the baseline reading during the period from intrathecal injection to delivery of the fetus)', 'timeFrame': '2 hours'}], 'secondaryOutcomes': [{'measure': 'systolic and diastolic blood pressures measured in mm Hg', 'timeFrame': '2 hours'}, {'measure': 'heart rate measured in beats per minute', 'timeFrame': '2 hours'}, {'measure': 'nausea and vomiting measured in number of attacks', 'timeFrame': '2 hours'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Adverse Anesthesia Outcome']}, 'descriptionModule': {'briefSummary': 'Hypotension following spinal anesthesia for cesarean section is a serious problem. In this study we investigated the effect of the vasopressors phenylephrine and noradrenaline on postspinal hypotension.', 'detailedDescription': 'On arrival to the operating room, an 18g cannula will be inserted and monitors will be applied (electrocardiography - pulse oximetry - non-invasive blood pressure monitor). Patients will receive spinal anesthesia with 500 ml rapid crystalloid co-load. Ten milligrams heavy bupivacaine in addition to 20 mcg fentanyl will be injected in L3-L4 or L4-L5 interspace using 25 g spinal needle in the sitting position.\n\nAfter spinal block, patients will be randomly allocated into one of two groups:\n\n* Phenylephrine group (n=100)\n* Norepinephrine group (n=100)\n\nPatients who shows SBP above 140 mmHg or heart rate below 55 bpm after the first vasopressor dose will not receive the infusion. The infusion will stop if the SBP was above 140 mmHg or if the heart rate was below 55 bpm. Patients will be positioned in the supine position with left lateral tilt. Block success will be assessed using pinprick, patients with failed block will be excluded from the study. The highest sensory block level will be assessed after 5 minutes from intrathecal injection. Co-hydration will be continued till maximum of 1.5 litres.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT'], 'maximumAge': '35 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* full term singleton parturients\n* elective cesarean sections\n\nExclusion Criteria:\n\n* cardiac morbidities\n* hypertensive disorders of pregnancy\n* peripartum bleeding\n* body mass index \\> 35 will be excluded from the study'}, 'identificationModule': {'nctId': 'NCT03015857', 'briefTitle': 'Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension', 'organization': {'class': 'OTHER', 'fullName': 'Kasr El Aini Hospital'}, 'officialTitle': 'A Comparison Between Phenylephrine and Norepinephrine Boluses in Prevention of Post-spinal Hypotension During Cesarean Delivery', 'orgStudyIdInfo': {'id': 'cesarean sections'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'phenylephrine,', 'description': '\\- Phenylephrine group (n=100): will receive 100 mcg phenylephrine as a single bolus just after intrathecal injection of 10 mg bupivacaine plus 20 mcg fentanyl. The dose will be diluted in 5 mL and given over seconds. A continuous infusion with placebo (normal saline) will start after the first bolus.', 'interventionNames': ['Drug: phenylephrine', 'Drug: Bupivacaine', 'Drug: Fentanyl', 'Drug: Placebo (normal saline)']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'norepinephrine', 'description': '\\- Norepinephrine group (n=100): will receive bolus of norepinephrine (10 mcg) directly after spinal block using 10 mg bupivacaine plus 20 mcg fentantanyl followed by continuous infusion of norepinephrine with a rate of 0.1 mcg/kg/min till delivery of the fetus.', 'interventionNames': ['Drug: Norepinephrine', 'Drug: Bupivacaine', 'Drug: Fentanyl']}], 'interventions': [{'name': 'phenylephrine', 'type': 'DRUG', 'description': '\\- phenylephrine; a vasopressor drug given to prevent post spinal hypotension', 'armGroupLabels': ['phenylephrine,']}, {'name': 'Norepinephrine', 'type': 'DRUG', 'description': '\\- norepinephrine; a vasopressor drug given to prevent post spinal hypotension', 'armGroupLabels': ['norepinephrine']}, {'name': 'Bupivacaine', 'type': 'DRUG', 'description': 'intrathecal bupivacaine 10 mg will be given in both groups', 'armGroupLabels': ['norepinephrine', 'phenylephrine,']}, {'name': 'Fentanyl', 'type': 'DRUG', 'description': 'intrathecal fentanyl 20 mcg will be given in both groups', 'armGroupLabels': ['norepinephrine', 'phenylephrine,']}, {'name': 'Placebo (normal saline)', 'type': 'DRUG', 'armGroupLabels': ['phenylephrine,']}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Shereen Refaat, M.D.', 'role': 'STUDY_CHAIR', 'affiliation': 'Lecturer of anesthesia Faculty of medicine Cairo university'}, {'name': 'Tamer M Rook, M.D.', 'role': 'STUDY_CHAIR', 'affiliation': 'Lecturer of anesthesia Faculty of medicine Cairo university'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Kasr El Aini Hospital', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal investigator and lecturer of anesthesia, faculty of medicine cairo university', 'investigatorFullName': 'ahmed elsakka', 'investigatorAffiliation': 'Kasr El Aini Hospital'}}}}